logo

Is consumer advertising for prescription drugs banned in most of the world?

Wednesday, December 9, 2020
By Meredith Hertan
YES

According to Harvard Medical School, the United States and New Zealand “are the only countries where drug makers are allowed to market prescription drugs directly to consumers.”

In the U.S., the Federal Trade Commission is responsible for regulating direct-to-consumer pharmaceutical advertising. According to Food & Drug Administration rules, drug ads must name “at least one approved use for the drug,” “the generic name of the drug” and all of its risks—or in some cases, only the most important risks.

Research demonstrates that consumer advertising has both benefits (empowering patients, encouraging them to speak with care providers and removing stigma around certain diseases) and drawbacks (overemphasizing drug benefits, leading to inappropriate prescriptions and increasing costs).

This fact brief is responsive to conversations such as this one.
ABOUT THE CONTRIBUTOR
Between 2020 and 2022, under close editorial supervision, Gigafact contracted a group of freelance writers and editors to test the concepts for fact briefs and provide inputs to our software development process. We call this effort Gigafact Foundry. Over the course of these two years, Gigafact Foundry writers published over 1500 fact briefs in response to claims they found online. Their important work forms the basis of Gigafact formats and editorial guidelines, and is available to the public on Gigafact.org. Readers should be aware that while there is still a lot of relevant information to be found, not all fact briefs produced by Gigafact Foundry reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date and need to be looked at with fresh eyes, don't hesitate to contact us at support@gigafact.org.
FACT BRIEF BY
facebook
twitter
email
email